Potential Corruption of Science About COVID 19

Aleš Pachmann –  AMBIS Vysoká škola, Praha Lindnerova 575/1 180 00 Praha 8 – Libeň, Czech Republic

7th International Scientific ERAZ Conference – ERAZ 2021 – Conference Proceedings: KNOWLEDGE BASED SUSTAINABLE DEVELOPMENT,  Online/virtual, May 27, 2021

ERAZ Conference Proceedings are published by: Association of Economists and Managers of the Balkans – Belgrade, Serbia

ERAZ conference partners: Faculty of Economics and Business, Mediterranean University, Montenegro; University of National and World Economy – Sofia, Bulgaria; Faculty of Commercial and Business Studies – Celje, Slovenia; AMBIS University, Prague – Czech Republic; Faculty of Applied Management, Economics and Finance – Belgrade, Serbia

ERAZ Conference 2021 Conference Proceedings: ISBN 978-86-80194-46-2, ISSN 2683-5568, DOI: https://doi.org/10.31410/ERAZ.2021

Abstract: Covid-19 is the disease. When someone is PCR test Sars-CoV-2 positive – it does not necessarily mean that such person is sick or spreads the virus. Clinical evaluation is needed to determine such information. The author of this paper examines the hypothesis that only sick (symptomat­ic) persons or persons with high viral load (under certain circumstances – coughing, sneezing and maybe loud talking and singing) can transfer Sars- CoV-2 to others.

This paper aims to analyse and evaluate other methods of testing for SARS-CoV-2 than PCR from nasopharyngeal swabs (or saliva/throat/front nose samples). Suggested is PCR testing from real clinical face masks samples to evaluate the condition of the test subject and his ability to spread the vi­rus. Potential corruption is in scientific claims that PCR testing from naso­pharyngeal swabs (or saliva/throat/front nose samples) is so-called “gold standard”.

A critical overview of current literature on this topic was provided and re­search with surface and air samples collections in hospitals in rooms with only symptomatic and only asymptomatic patients. Recommendations for public policy are done.

ERAZ Conference

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission. 

References

Amirian, E. S. (2020). Potential fecal transmission of SARS-CoV-2: Current evidence and im­plications for public health. International Journal of infectious diseases, 95, 363-370.

Cao, S., Gan, Y., Wang, C., Bachmann, M., Wei, S., Gong, J., … & Lu, Z. (2020). Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China. Na­ture communications, 11(1), 1-7.

Cheng, V. C. C., Wong, S. C., Chan, V. W. M., So, S. Y. C., Chen, J. H. K., Yip, C. C. Y., … & Yuen, K. Y. (2020). Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19). Infection Control & Hospital Epide­miology, 41(11), 1258-1265.

Faridi, S., Niazi, S., Sadeghi, K., Naddafi, K., Yavarian, J., Shamsipour, M., … & MokhtariAzad, T. (2020). A field indoor air measurement of SARS-CoV-2 in the patient rooms of the larg­est hospital in Iran. Science of the Total Environment, 725, 138401.

Ganyani, T., Kremer, C., Chen, D., Torneri, A., Faes, C., Wallinga, J., & Hens, N. (2020). Es­timating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Eurosurveillance, 25(17), 2000257

Park, S. K., Lee, C. W., Park, D. I., Woo, H. Y., Cheong, H. S., Shin, H. C., … & Joo, E. J. (2021). Detection of SARS-CoV-2 in fecal samples from patients with asymptomatic and mild COVID-19 in Korea. Clinical Gastroenterology and Hepatology, 19(7), 1387-1394.

Zimmermann, P., & Curtis, N. (2020). Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. The Pediatric infectious disease journal, 39(5), 355.

Lavezzo, E., Franchin, E., Ciavarella, C., Cuomo-Dannenburg, G., Barzon, L., Del Vecchio, C., … & Crisanti, A. (2020). Suppression of a SARS-CoV-2 outbreak in the Italian municipal­ity of Vo’. Nature, 584(7821), 425-429.

Lednicky, J. A., Lauzard, M., Fan, Z. H., Jutla, A., Tilly, T. B., Gangwar, M., … & Wu, C. Y. (2020). Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Inter­national Journal of Infectious Diseases, 100, 476-482.

Lee, S., Kim, T., Lee, E., Lee, C., Kim, H., Rhee, H., … & Kim, T. H. (2020). Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea. JAMA internal medicine, 180(11), 1447-1452.

Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020). Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance, 25(10), 2000180.

Smolinska, A., Jessop, D. S., Pappan, K. L., De Saedeleer, A., Kang, A., Martin, A. L., … & van der Schee, M. P. (2021). The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs. Scientific Reports, 11(1), 1-11.

Wei, W. E., Li, Z., Chiew, C. J., Yong, S. E., Toh, M. P., & Lee, V. J. (2020). Presymptomatic transmission of SARS-CoV-2—Singapore, January 23–March 16, 2020. Morbidity and Mortality Weekly Report, 69(14), 411.

Williams, C. M., Pan, D., Decker, J., Wisniewska, A., Fletcher, E., Sze, S., … & Barer, M. R. (2021). Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19. Journal of Infection, 82(6), 253-259.